Ikeda, Japan

Yoko Akazawa

This inventor holds 1 USPTO granted patent. Top assignee: Jsr Corporation. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoko Akazawa: Innovator in Antibody Technology

Introduction

Yoko Akazawa is a notable inventor based in Ikeda, Japan, recognized for her contributions to the field of biotechnology. She has developed a groundbreaking patent that leverages the unique properties of mutant VHH antibodies to enhance the capabilities of affinity carriers.

Latest Patents

Akazawa holds a patent titled "Affinity carrier using mutant VHH antibody." This innovative technology involves an affinity carrier that includes a solid phase carrier and an immunoglobulin-binding protein, which is either a mutant VHH antibody or a fragment of it. This antibody is designed to recognize specific epitopes found in certain amino acid sequences, thereby significantly advancing the development of targeted therapies and diagnostic tools.

Career Highlights

Yoko Akazawa is affiliated with JSR Corporation, where she has dedicated her expertise to pioneering advancements in antibody technology. Her work has not only expanded the scientific understanding of VHH antibodies but has also positioned her as a forerunner in the industrial application of such innovations.

Collaborations

Throughout her career, Akazawa has collaborated with esteemed colleagues, including Yoshihisa Hagihara and Yuji Ito. These partnerships have fostered an environment of creativity and knowledge-sharing, further enhancing the impact of her research and inventions.

Conclusion

Yoko Akazawa's contributions to biotechnology reflect her commitment to innovation and excellence. Her patent on the affinity carrier using mutant VHH antibodies positions her as a key player in the development of advanced therapeutic solutions, inspiring future generations of inventors in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…